Cornea/External Disease News

The FDA has approved the first generic version of Restasis, according to a press release.

Tarsus Pharmaceuticals has completed enrollment in the second pivotal phase 3 trial investigating TP-03 for the treatment of Demodex blepharitis and secured a $175 million credit facility, according to a press release.

WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2022, Laura M. Periman, MD, discusses a case of dupilumab-induced ocular surface disease and management strategies.

Do you ever wonder why there are so many dry eye treatments coming to market?

When assessing a patient with dry eye, I try to determine the primary problem.

Over the last 18 months, rapid developments have occurred in the dry eye and ocular surface disease space.

Ocular surface disease includes as major diagnoses dry eye disease, blepharitis/meibomian gland dysfunction and ocular allergy.

Descemet’s stripping endothelial keratoplasty, Descemet’s membrane endothelial keratoplasty and pre-Descemet’s endothelial keratoplasty have changed the cornea transplant game.

WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2022, Laura M. Periman, MD, discusses allergic conjunctivitis, dry eye disease and the role of Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix).

WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2022, Kathryn M. Hatch, MD, explains why cornea specialists strive for “one and done” when treating keratoconus and other epithelial defects with collagen cross-linking.